Summary
Effects of the administration of a thromboxane A2 (TXA2) analogue (STA2), a leukotriene C4 (LTC4), and a leukotriene D4 (LTD4) on regional myocardial blood flow (RMBF) and hemodynamics were studied in anesthetized, open-chest dogs. The blocking ability of a recently synthesized TXA2 selective antagonist, ONO-3708, and a peptidoleukotriene-selective antagonist, ONO-1078, was also investigated. RMBF was measured continuously in three areas: the left anterior descending coronary artery (LAD) area, the circumflex artery (Cx) area, and the area between LAD and Cx. STA2, LTC4, and LTD4 caused a significant dose-dependent reduction of the RMBF in the LAD area. The peak percentage decrease in RMBF followed by a 10 µg dose of STA2, 1 µg dose of LTC4, and 1 µg dose of LTD4 is 38.6%±3.0%, 39.0%±3.1%, and 36.2%±2.4%, respectively. ED50 for the action of LTC4, LTD4, and STA2 on RMBF is 3, 3, and 50 µg, respectively. Pretreatment with the newly developed TXA2 antagonist, ONO-3708 (1 µg/kg/min for 10 min), completely inhibited the RMBF reduction induced by STA2 (10 µg). Pretreatment with the peptidoleukotriene antagonist, ONO-1078 (1 mg), inhibited the RMBF reduction induced by LTC4 or LTD4 (0.3–3 µg). Following pretreatment with a 1 mg dose of ONO-1078, the peak percentage decrease of RMBF caused by a 1 µg dose of LTC4 and LTD4 was reduced to 21.1%±2.3% and 19.8%±3.1%, respectively. However, the LTC4 (1 µg)-induced reduction of the RMBF was not affected by pretreatment with a TXA2 antagonist, ONO-3708, or an inhibitor of the endogenous production of TXA2, OKY-046. Likewise, the reduction of the RMBF induced by STA2 (10 µg) was not affected by pretreatment with a leukotriene-antagonist, ONO-1078. These results suggest that the reduction of RMBF induced by TXA2, LTC4, and LTD4 is mediated in vivo through different vascular receptors for each.
Similar content being viewed by others
References
Ellis EF, Oelz O, Roberts LJ II, Payne NA, Sweetman BJ, Nies AS, Oates JA (1976) Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science 193: 1135–1137
Needleman P, Kulkarni PS, Raz A (1977) Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes. Science 195: 409–412
Hand JM, Will JA, Buckner CK (1981) Effects of leukotrienes on isolated guinea-pig pulmonary arteries. Eur J Pharmacol 76: 439–442
Terashita ZI, Fukui H, Hirata M, Terao S, Ohkawa S, Nishikawa K, Kikuchi S (1981) Coronary vasoconstriction and PGI2 release by leukotrienes in isolated guinea pig hearts. Eur J Pharmacol 73: 357–361
Burke JA, Levi R, Guo ZG, Corey EJ (1982) Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro. J Pharmacol Exp Ther 221: 235–241
Letts LG, Piper PJ (1982) The actions of leukotrienes C4 and D4 on guinea-pig isolated hearts. Br J Pharmacol 76: 169–176
Michelassi F, Landa L, Hill RD, Lowenstein E, Watkins WD, Petkau AJ, Zapol WM (1982) Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science 217: 841–843
Boyd LM, Ezra D, Feuerstein G, Goldstein RE (1983) Effects of FPL-55712 or indomethacin on leukotriene-induced coronary constriction in the intact pig heart. Eur J Pharmacol 89: 307–311
Letts LG, Newman DL, Greenwald SE, Piper PJ (1983) Effects of intra-coronary administration of leukotriene D4 in the anaesthetized dog. Prostaglandins 26: 563–572
Woodman OL, Dusting GJ (1983) Coronary vasoconstriction induced by leukotrienes in the anaesthetized dog. Eur J Pharmacol 86: 125–128
Panzenbeck MJ, Kaley G (1983) Leukotriene D4 reduces coronary blood flow in the anesthetized dog. Prostaglandins 25: 661–670
Engineer DM, Morris HR, Piper PJ, Sirois P (1978) The release of prostaglandins and thromboxanes from guinea-pig lung by slow reacting substance of anaphylaxis, and its inhibition. Br J Pharmacol 64: 211–218
Kennedy I, Coleman RA, Humphrey PPA, Levy GP, Lumley P (1982) Studies on the characterisation of prostanoid receptors: a proposed classification. Prostaglandins 24: 667–689
Hogaboom GK, Mong S, Wu HL, Crooke ST (1983) Peptidoleukotrienes: distinct receptors for leukotriene C4 and D4 in the guinea-pig lung. Biochem Biophys Res Commun 116: 1136–1143
Obata T, Katsube N, Miyamoto T, Toda M, Okegawa T, Nakai H, Kosuge S, Konno M, Arai Y, Kawasaki A (1985) New antagonists of leukotrienes: ONO-RS-411 and ONO-RS-347. In: Hayaishi O, Yamamoto S (eds) Advances in prostaglandin, thromboxane, and leukotriene research. Raven Press, New York, pp 229–231 (Kyoto Conference on Prostaglandins, vol. 15)
Yui Y, Sakaguchi K, Susawa T, Hattori R, Takatsu Y, Yui N, Kawai C (1987) Thromboxane A2 analogue induced coronary artery vasoconstriction in the rabbit. Cardiovasc Res 21: 119–123
Uchida Y, Ueda H (1971) Evaluation of the use of heated cross-thermocouples for assessments of regional myocardial blood flow. Jpn Heart J 12: 562–574
Aukland K, Bower BF, Berliner RW (1964) Measurement of local blood flow with hydrogen gas. Circ Res 14: 164–187
Betz E, Ingvar DH, Lassen NA, Schmahl FW (1966) Regional blood flow in the cerebral cortex, measured simultaneously by heat and inert gas clearance. Acta Physiol Scand 67: 1–9
Sakai K, Ito T, Ogawa K (1982) Roles of endogenous prostacyclin and thromboxane A2 in the ischemic canine heart. J Cardiovasc Pharmacol 4: 129–135
Saussy DL Jr, Mais DE, Knapp DR, Halushka PV (1985) Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle. Circulation 72: 1202–1207
Mais DE, Saussy DL Jr, Chaikhouni A, Kochel PJ, Knapp DR, Hamanaka N, Halushka PV (1985) Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. J Pharmacol Exp Ther 233: 418–424
Toki Y, Hieda N, Torii T, Hashimoto H, Ito T, Ogawa K, Satake T (1988) The effects of lipoxygenase inhibitor and peptidoleukotriene antagonist on myocardial injury in a canine coronary occlusion-reperfusion model. Prostaglandins 35: 555–571
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Torii, T., Toki, Y., Hieda, N. et al. Effects of a new thromboxane A2-antagonist (ONO-3708) and a new leukotriene-antagonist (ONO-1078) on thromboxane A2 analogue-, leukotriene C4-, and D4-induced regional myocardial blood flow reduction. Heart Vessels 4, 104–111 (1988). https://doi.org/10.1007/BF02058997
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02058997